The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA.
Interactions between the lamb uterine estrogen receptor occupied by estradiol, 4-hydroxytamoxifen (a non-steroidal partial estrogen antagonist) or ICI 164,384 (a steroidal pure estrogen antagonist), and the vitellogenin A2 estrogen-response element (vit ERE) were compared using a biotinylated 25-base all-palindromic double-stranded oligonucleotide, containing vit ERE (b-ERE), which allowed isolation of the b-ERE.receptor.[3H]ligand assembly on streptavidin-Sepharose. The results of saturation analyses of the three receptor.[3H]ligand complexes by increasing amounts of b-ERE were quite similar for the proportion of complexes able to interact with b-ERE (which varied from 30% to 65% according to experiments) and for the equilibrium dissociation constant [Kd (0 degree C) approximately 1.2 nM, assuming that the receptor interacted as a dimer with b-ERE]. With each ligand, receptor binding to ERE did not change the rate of ligand dissociation from the receptor at 20 degrees C. The rate of estrogen receptor dissociation from b-ERE, measured at 20 degrees C in the presence of a given concentration of ERE, did not vary according to the ligand bound to the receptor; however, this dissociation rate increased linearly over the ERE concentration range (0.5-10 microM). The experimental rate constant (k-) of estrogen receptor dissociation from b-ERE appeared to be the sum of the basal dissociation-rate constant (k degrees - approximately 0.011 min-1), corresponding to spontaneous dissociation which would occur in the absence of ERE, and of the ERE-induced dissociation-rate constant, proportional to the used concentration of ERE (ki- approximately 4500 CERE M-1 min-1, where CERE is the molar concentration of ERE). Non-target DNA also induced receptor dissociation from b-ERE, but its efficiency was 6-10-fold lower than that of ERE. We conclude that, the two antiestrogens are as efficient as estradiol in promoting estrogen receptor binding to a single vit ERE; the low or nil ability of antiestrogens to induce estrogenic responses is probably not linked with the receptor DNA-binding step; DNA binding does not seem to affect the conformation of the filled hormone-binding site of the receptor at 20 degrees C; interactions of receptor dimers with DNA seems to proceed by direct transfer of receptor dimers between DNA strands.
Aliau
S
S
Institut National de la Santé et de la Recherche Médicale, Montpellier, France.
Groblewski
T
T
Borgna
J L
JL
D000818:Animals; D001426:Bacterial Proteins / Q000378:metabolism; D001483:Base Sequence; D004247:DNA / Q000378:metabolism / Q000494:pharmacology*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000378:metabolism; D004965:Estrogen Antagonists / Q000378:metabolism*; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D008969:Molecular Sequence Data; D053284:Polyunsaturated Alkamides; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000378:metabolism; D012756:Sheep; D019809:Streptavidin; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000378:metabolism
D001426:Bacterial Proteins; D004965:Estrogen Antagonists; D004967:Estrogens; D053284:Polyunsaturated Alkamides; D011960:Receptors, Estrogen; D013629:Tamoxifen; C016601:afimoxifene; D004958:Estradiol; C051781:ICI 164384; D004247:DNA; D019809:Streptavidin